Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

FHS
June 21, 2024
4:35 pm

Drugs developed to combat HIV and AIDS are being trialed for the first time in patients with multiple brain tumors.

Updated: Flagship merges its troubled circular RNA company Laronde with nanoparticle startup Senda

Laronde and Senda Biosciences, two biotech startups founded by Flagship Pioneering that collectively raised more than $750 million, are merging to form a new company

October 20, 2023

Neural circuits provide clues for better AI matching solutions

When you ask a rideshare app to find you a car, the company’s computers get to work. They know you want to reach your destination

September 3, 2024

Blood Test for CRC Screening Lags Behind Other Options in Cost-Effectiveness Study

New blood-based screening tests for colorectal cancer (CRC) offered fewer benefits at higher cost versus other screening options, a cost-effectiveness modeling study suggested. In a

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.